Nanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic Phenotype - Wikidata - wikimedia - TriplyDB

Nanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic Phenotype

Nanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic Phenotype

http://www.wikidata.org/entity/Q26779454

about

Inherited heart disease - what can we expect from the second decade of human iPS cell research?Isolation and Mechanical Measurements of Myofibrils from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Muscular dystrophy in a dish: engineered human skeletal muscle mimetics for disease modeling and drug discovery.Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening.Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes.A biomaterial approach to cell reprogramming and differentiation.Multiscale technologies for treatment of ischemic cardiomyopathy.CRISPR Genome Engineering for Human Pluripotent Stem Cell Research.Harnessing Sphingosine-1-Phosphate Signaling and Nanotopographical Cues To Regulate Skeletal Muscle Maturation and Vascularization.Regulation of skeletal myotube formation and alignment by nanotopographically controlled cell-secreted extracellular matrix.Facile fabrication of tissue-engineered constructs using nanopatterned cell sheets and magnetic levitation.Tissue engineering toward organ-specific regeneration and disease modeling.Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine

P2860

Q28079217-2DB5B6F6-8C17-4590-8EF5-C90A161760B2 Q37014695-E1A1329E-A4D2-43B2-8F1E-A8FFF79B02B9 Q38816248-BEBF534C-FEA6-4868-B4E7-EF8B4653EB0C Q39010745-5FBC7E32-633A-4786-A3C5-F816D20E319E Q39050993-3FC0E31F-FCC9-4B80-8DA0-C0224B8C5805 Q39345477-3DCAEC3A-F948-4966-9A1E-9DFDAF8F0423 Q41926984-C87EE332-D6E9-4360-8762-B0E80E839B9A Q46454164-F6D2DCC9-690A-4C70-A643-42EAFEF6EB77 Q46522290-1578F8BB-8EE1-465F-8BCB-EB92979FC6F0 Q47331552-6B382997-A5BC-4950-8D4E-C2FD08A9A05B Q48169198-061F5BD2-0F49-4680-9714-68DCB9899D04 Q49411044-A0093C37-70FB-4C71-B676-6D2A2FDBE00C Q55316142-52715A4D-29C4-4867-95B5-AA2327C42ABF Q58716650-56CD3A63-72D9-446E-8614-DCD1B3C171ED

P2860

Nanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic Phenotype

http://www.wikidata.org/entity/Q26779454

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Nanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic Phenotype

@ast

Nanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic Phenotype

@en

Nanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic Phenotype

@nl

type

label

Nanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic Phenotype

@ast

Nanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic Phenotype

@en

Nanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic Phenotype

@nl

prefLabel

Nanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic Phenotype

@ast

Nanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic Phenotype

@en

Nanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic Phenotype

@nl

P1433

Q26779454-9DA2B037-B55B-4A22-95DD-8408E441B338

P1476

Q26779454-8AAC8534-D379-4BE3-8C77-00DA89FA6737

P2093

Q26779454-11F67ED9-9B5D-4C4E-8C50-599932C18FF3

Q26779454-142995A4-8905-40E2-9BEE-5ED0651396B3

Q26779454-2459DFBA-EDF8-447A-AA8D-2E7CC0284FC9

Q26779454-4FF21376-F566-41A4-9CB0-A447F0C06555

Q26779454-AD406669-D692-4B55-9E79-46F47C0623DB

Q26779454-EDFEAEB8-B6F9-47B9-B434-13E1168A93C0

Q26779454-EF622E6E-B0B7-48EC-99CC-6A2790DC543A

P2860

Q26779454-07DAC26F-8A4F-4457-AE90-D50A63A4C409

Q26779454-0CBE35E8-3C2B-4A51-8EE2-EB9EA18B0FD7

Q26779454-0CFD87E2-27CF-4343-82B1-9F98BFCF8743

Q26779454-118D9B09-866A-4F94-B6F9-A458B7791823

Q26779454-18DAFB6D-83FF-4E7F-800B-EB943768DF2D

Q26779454-3556B22F-2B94-4DEF-A8DC-D4BA577DB4A1

Q26779454-3D22AECF-B5C8-43AF-8FAA-BCEB3B3A1104

Q26779454-53D9BF84-60E2-4869-A585-1AD75D32584F

Q26779454-5E1A3E42-C460-4829-A675-5F054D17278F

Q26779454-6BA6FF5B-D409-4C32-87E0-0176BA16389C

P2888

Q26779454-33B0D8BC-F3B5-472B-B722-39FB693F29CC

P304

Q26779454-199028BB-DA3B-4BF4-99AA-904A208D793C

P31

Q26779454-22DA0DF0-3787-45F4-B470-E6353F1CF5CF

P3181

Q26779454-0B3B8440-3CAE-4B2E-A06C-1BCE3A994EDA

P356

Q26779454-9B0AC732-2D83-4AF2-9BA2-7D95C3631372

P433

Q26779454-36436DF2-CB5A-45C4-B577-BD5FA8C6CBC4

P478

Q26779454-973E9FF1-987B-42C5-8D33-E36509868510

P50

Q26779454-E036E83B-8CD2-4E0B-8524-1FA1AED33378

P577

Q26779454-6E487238-F50F-40E6-A527-DFC2319DA782

P5875

Q26779454-84FDFB28-7DFE-4CB6-AA9E-C6EACD98846E

P6179

Q26779454-28BCFE34-DA1C-4172-AC29-2F0C60F2DDF9

P698

Q26779454-EA353DB6-39B4-4B0A-94FB-0EBC9A2B48E3

P932

Q26779454-27127F99-E7DA-4D96-BB69-08D6C08AD12E

P3181

P356

S12195-015-0413-8

P1433

Cellular and Molecular Bioengineering

P1476

Nanopatterned Human iPSC-based Model of a Dystrophin-Null Cardiomyopathic Phenotype

@en

P2093

Alec S T Smith

http://www.w3.org/2001/XMLSchema#string

David L Mack

http://www.w3.org/2001/XMLSchema#string

Jesse Macadangdang

http://www.w3.org/2001/XMLSchema#string

Martin K Childers

http://www.w3.org/2001/XMLSchema#string

Rachel Lucero

http://www.w3.org/2001/XMLSchema#string

Stefan Czerniecki

http://www.w3.org/2001/XMLSchema#string

Xuan Guan

http://www.w3.org/2001/XMLSchema#string

P2860

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Genome engineering using the CRISPR-Cas9 system

Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity

Multiplex genome engineering using CRISPR/Cas systems

Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy

Screening system for drug-induced arrhythmogenic risk combining a patch clamp and heart simulator.

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

Modelling the long QT syndrome with induced pluripotent stem cells

Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs.

P2888

s12195-015-0413-8

P304

320-332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1892682

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S12195-015-0413-8

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281852650

http://www.w3.org/2001/XMLSchema#string

P6179

1035817677

http://www.w3.org/2001/XMLSchema#string

P698

26366230

http://www.w3.org/2001/XMLSchema#string

P932

4564135

http://www.w3.org/2001/XMLSchema#string